Randomized Controlled Trial of Mobile Closed-Loop Control.
Boris KovatchevStacey M AndersonDan RaghinaruYogish C KudvaLori M B LaffelCarol LevyJordan E PinskerR Paul WadwaBruce BuckinghamFrancis J Doyle IiiSue A BrownMei Mei ChurchVikash DadlaniEyal DassauLaya EkhlaspourGregory P ForlenzaElvira IsganaitisDavid W LamJohn W LumRoy W Becknull nullPublished in: Diabetes care (2020)
In meeting its coprimary end points, superiority of CLC over SAP in CGM-measured time below 3.9 mmol/L and noninferiority in CGM-measured time above 10 mmol/L, the study has demonstrated that mobile CLC is feasible and could offer certain usability advantages over embedded systems, provided the connectivity between system components is stable.